yourstate.us
21 CFR 520.622b

§ 520.622b Diethylcarbamazine citrate syrup.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 520.622b, § 520.622b Diethylcarbamazine citrate syrup, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87134
Permanent ID
ys:prov:87134@1
SHA-256
15e2e8b10cc5315f3e194dfef3005307c29e8bb0d4ad496edfcc5c345d3310c8

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a)(1) Specifications. Each milliliter of syrup contains 60 milligrams of diethylcarbamazine citrate. (2) Sponsor. See No. 054771 in § 510.600(c) of this chapter. (3) Conditions of use. (i) The drug is indicated for use in dogs for the prevention of infection with Dirofilaria immitis and T. canis and T. leonina. It is also indicated for treatment of ascarid infections of T. canis and T. leonina in dogs and T. cati in cats. (ii) For prevention of heartworm and ascarid infections in dogs, the drug may be added to the daily diet at a dosage rate of 3.0 milligrams per pound of body weight per day or given directly by mouth at the same dosage rate. For treatment of ascarid infections in dogs and cats, the drug is administered at a dosage level of 25 to 50 milligrams per pound of body weight preferably administered immediately after feeding. (iii) Older dogs should be proven negative for the presence of Dirofilaria immitis infection before administration of the drug. Those with proven infection of Dirofilaria immitis should be rendered negative using adulticidal and microfilaricidal drugs before administration of this drug. (iv) Federal law restricts this drug to use by or on the order of a licensed veterinarian. (b) [Reserved] (c)(1) Specifications. Each milliliter of syrup contains 60 milligrams of diethylcarbamazine citrate. (2) Sponsor. See No. 069043 in § 510.600(c) of this chapter. (3) Conditions of use. (i) The drug is used in dogs between 4 weeks and 8 months of age for the removal of ascarids (Toxacara canis) and in animals over 4 weeks of age for the prevention of heartworm disease (Dirofilaria immitis). (ii) The drug is administered (a) for removal of ascarids at a dosage of 50 milligrams per pound of body weight divided into two equal doses and administered 8 to 12 hours apart (morning and night), orally or mixed with either dry or wet food, and (b) for prevention of heartworm disease at a dosage of 3 milligrams per pound of body weight daily, orally or in food, in heartworm endemic areas, from the beginning of mosquito activity, during the mosquito season, and for 2 months following the end thereof. (iii) Dogs older than 8 months of age may be infected with Dirofilaria immitis. Use of the drug is contraindicated in dogs with active D. immitis infections. (iv) Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.